Related Experiment Video

Updated: Apr 29, 2026

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
06:13

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells

Published on: January 16, 2026

133

Down-regulation of miR-3928 promoted osteosarcoma growth

Haidong Xu1, Xiaozhou Liu, Jianning Zhao

  • 1Department of Orthopedics of Jinling Hospital, Nanjing University, School of Medicine, Nanjing, China.

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|May 24, 2014
PubMed
Abstract

Insights

MicroRNA-3928 (miR-3928) is downregulated in osteosarcoma, inhibiting tumor growth and promoting apoptosis. Restoring miR-3928 levels may offer a new therapeutic strategy for osteosarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a common childhood bone cancer with frequent treatment failures due to chemotherapy resistance.
  • Understanding the molecular mechanisms of osteosarcoma pathogenesis is crucial for developing novel therapies.
  • MicroRNAs (miRNAs) play significant roles in the development of osteosarcoma.

Purpose of the Study:

  • To investigate the role of miR-3928 in osteosarcoma.
  • To identify potential therapeutic targets for osteosarcoma.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure miR-3928 expression.
  • Transfection with miRNA mimics or antisense oligonucleotides (ASO) to modulate miR-3928 levels.
  • Cell proliferation, apoptosis, and cell cycle assays (formazan test, FACS).
  • Bioinformatic prediction of miR-3928 target genes using TargetScanHuman.
  • Pearson correlation analysis to assess gene-miRNA correlation.

Main Results:

  • miR-3928 expression was significantly downregulated in osteosarcoma tissues.
  • Overexpression of miR-3928 suppressed tumor growth, induced apoptosis, and altered cell cycle distribution (increased G1, decreased S phase).
  • Downregulation of miR-3928 promoted osteosarcoma cell proliferation.
  • ERBB3, IL-6R, and CDK6 were identified as potential direct targets of miR-3928.

Conclusions:

  • Downregulation of miR-3928 contributes to osteosarcoma progression by targeting ERBB3, IL-6R, and CDK6.
  • miR-3928 represents a promising therapeutic target for osteosarcoma, warranting further investigation.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K